Edwards Announces Key Events For PCR London Valves 2017

LONDON, Sept. 24, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced key events for the company during the PCR London Valves 2017 course, as the...